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Abstract The association between body mass index
(BMI) and survival has been described in various popula-
tions. However, the results remain controversial and
information from low-prevalence Western countries is
sparse. Our aim was to examine this association and its
public health impact in Switzerland, a country with inter-
nationally low mortality rate and obesity prevalence. We
included 9,853 men and women aged 25–74 years who
participated in the Swiss MONICA (MONItoring of trends
and determinants in CArdiovscular disease) study
(1983–1992) and could be followed up for survival until
2008 by using anonymous record linkage. Cox regression
models were used to calculate mortality hazard ratios
(HRs) and to estimate excess deaths. Independent variables
were age, sex, survey wave, diet, physical activity, smok-
ing, educational class. After adjustment for age and sex the
association between BMI and all-cause mortality was
J shaped (non-smokers) or U shaped (smokers). Compared
to BMI 18.5–24.9, among those with BMI C 30 (obesity)
HR for all-cause mortality was 1.41 (95% confidence
interval: 1.23–1.62), for cardiovascular disease (CVD) 2.05
(1.60–2.62), for cancer 1.29 (1.04–1.60). Further adjust-
ment attenuated the obesity-mortality relationship but the
associations remained statistically significant. No signifi-
cant increase was found for overweight (BMI 25–29.9).
Between 4 and 6.5% of all deaths, 8.8–13.7% of CVD
deaths and 2.4–3.9% of cancer deaths could be attributed to
obesity. Obesity, but not overweight was associated with
excess mortality, mainly because of an increased risk of
death from CVD and cancer. Public health interventions
should focus on preventing normal- and overweight per-
sons from becoming obese.
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Introduction
Worldwide, the prevalence of overweight and obesity
increased over the past decades and has become a major
burden for societies. Excess weight is associated with an
increased risk of disease and death, particularly from car-
diovascular disease (CVD) and cancer [1–3]. The associ-
ation between BMI and mortality substantially varies
between populations and causes of death [1, 3–6] and can
change over time [2, 5]. A part of this variation could be
due to shortcomings originating from data assessment or
induced in data analyses or interpretation. For example, in
many studies, data is self-reported or does not stem from
general populations but from selected groups such as
physicians, [7, 8] nurses [9] or alumni [10]. Also, infor-
mation from low-prevalence Western countries is sparse.
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The calculation and interpretation of relative risks could
become critical in countries with high prevalence because
the reference population (normal weight persons) becomes
an increasingly selected minority [2]. This may be an
explanation for the ‘‘obesity paradox’’, where individuals
with excess weight were found to have longer survival and
fewer CVD events [6, 11]. In many studies, the U shape of
the association between BMI and mortality risk was more
pronounced among smokers than among non-smokers [5,
12, 13]. In order to estimate the independent contribution
of excess weight, one should also consider that obese
persons may differ in socioeconomic status and other
lifestyle behaviours, e.g., regarding diet and physical
activity. It is also unclear to what extent the risk associated
with excess weight measured by BMI is accounted for by
intermediate CVD risk factors such as high blood pressure
and cholesterol level.
We aimed at determining the risk and burden of death
associated with BMI on a population level. For this pur-
pose, our study population can be regarded as exceptional.
Switzerland has lower mortality (particularly for CVD) and
a lower prevalence of obesity than most other countries
[14]. Obesity prevalence in Switzerland is about half of
that of the European average, a third of that of the UK and
a quarter of that of the US [14, 15]. BMI was based on
measured weight and height, and over 90% of participants
could be followed-up for up to 25 years. The database
includes a large set of social, behavioural and clinical
parameters thus, offering the possibility to consider
potential confounders or effect modifier in the analysis and
to evaluate the independent effect of excess weight.
Methods
Study population
Included individuals (25–74 years) were participants of the
Swiss MONICA (MONItoring of trends and determinants
in CArdiovscular disease) study. MONICA is an interna-
tional multicentre project initiated and coordinated by the
World Health Organization (WHO) [16]. In Switzerland,
the study has been conducted in three waves between 1983
and 1992 [17, 18]. Sampled persons were invited to attend
a health examination in their community of residence and
to complete a self-administered questionnaire. The partic-
ipation rate varied between 54 and 78% [19]. As in virtu-
ally all MONICA centres, no provision was made for a
mortality follow-up. Recently, in Switzerland, this short-
coming could be overcome by an anonymous record link-
age with the Swiss National Cohort (SNC) [20]. Details of
the study population are given in Table 1. For the calcu-
lation of excess deaths attributable to obesity we used
prevalence from two studies conducted in 2003 (measure-
ment) and 2007 (self-report) [21, 22].
Record linkage procedure
In order to determine survival, data from the SNC
including information on cause of death was linked to
MONICA participant records. The SNC encompasses all
residents of Switzerland enumerated in the national 1990 or
2000 censuses (6.8 and 7.3 million, respectively). Deter-
ministic and probabilistic methods were used to link
anonymised census, death and emigration records [23].
Also, record linkage of MONICA and the SNC based
exclusively on anonymous records [20]. 97.8% of the eli-
gible 10,160 MONICA participants could be linked to a
census (1990: 9,737; 2000: 8,749), mortality (1,526,
1984–2008) and/or emigration record (320, 1990–2008).
83 participants of the last wave of MONICA could only be
linked to the preceding 1990 census but not to a subsequent
census, mortality or emigration record, thus, leaving 9,853
individuals for survival analysis. Linkage procedures and
linkage success were described in detail [20].
Exposure variables
Education, lifestyle and clinical risk factors stem from
MONICA. Measurements and blood sampling procedures
have been described [17–19]. BMI was calculated from
measured height (cm) and weight (kg) by dividing weight
by height squared (kg/m2). Underweight (BMI \ 18.5 kg/
m2), normal weight (BMI 18.5–24.9 kg/m2), overweight
(BMI 25–29.9 kg/m2) and obesity (C30 kg/m2) were
defined according to the WHO criteria [24].
The following educational classes were used: (i) ‘‘Man-
datory’’: compulsory schooling (corresponding to com-
pleted 8th US grade) or less (International Standard
Classification of Education, ISCED 1 and 2); (ii) ‘‘Sec-
ondary’’: vocational training or high school (completed
12th US grade; ISCED 3); (iii) ‘‘Tertiary’’: technical col-
lege, upper vocational or university education (ISCED 5)
[25, 26].
In order to look for the risk factor variables providing
the most robust results after adjustment, we performed
sensitivity analyses with smoking status (number of ciga-
rettes smoked daily; never, former and current smokers;
regular smokers, occasional smokers, non-smokers), blood
cholesterol (total cholesterol, HDL-cholesterol, ratio of
total cholesterol/HDL-cholesterol), blood pressure (dia-
stolic and systolic, derived four blood pressure categories,
known hypertension, hypertension treatment). We finally
selected current regular and occasional smokers and non-
smokers (including former smokers). Construction of diet
and physical activity scores is described in the Web Annex.
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For separate analyses we used cholesterol ratio and the four
blood pressure categories according to the American Heart
Association [27].
Outcome variables
Causes of death were classified according to ICD (Inter-
national Classification of Diseases) revisions 8 (ICD-8) and
10 (ICD-10). In Switzerland ICD-8 was used until 1994
followed by ICD-10 thereafter. Due to the relatively small
number of deaths, causes of death had to be grouped into
CVD (ICD-8: 410–438; ICD-10: I00–I99), cancer (ICD-8:
140–239; ICD-10: C00–C99; D00–D48), and non-cancer-
non-CVD (remainder).
Statistical analyses
In a first step, we performed all analyses separately by sex.
We found no significant sex differences, neither in obesity
prevalence, nor in obesity related hazard ratio (HRs). In
order to obtain more robust estimates, we decided to pool
sexes. Kaplan–Meier curves were calculated for all-cause
mortality as well as separately for CVD, cancer and non-
cancer-non-CVD, using appropriate methods to account for
competing risks. For the estimation of HRs, we fitted a Cox
Table 1 Characteristics (counts, means and proportions) of the study population, by BMI category, 9,853 participants of the Swiss MONICA
study, 1983–92, 25–74 years at baseline
Total Body mass index category (kg/m2)*
\18.5 18.5–24.9 25–29.9 C30
Participants (n) 9,853 167 4,590 3,789 1,307
Prevalence (%) 100 1.7 46.7 38.5 13.1
Women (%) 49.6 86.2 59.6 37.1 46.0
Mean age (years) 47.2 44.7 (42.6–46.8) 44.4 (44.1–44.7) 48.9 (48.6–49.3) 52.0 (51.4–52.6)
Mean follow-up time (years) 18.6 18.5 (17.7–19.3) 19.0 (18.8–19.1) 18.4 (18.3–18.6) 17.7 (17.5–18.0)
Education
Tertiary (%) 19.3 28.9 (21.9–35.9) 23.9 (22.7–25.1) 16.2 (15.0–17.1) 10.9 (9.2–12.6)
Upper secondary (%) 48.7 51.2 (43.5–58.9) 51.5 (50.0–52.9) 47.7 (46.2–49.4) 41.5 (38.8–44.2)
Mandatory and secondary (%) 32.0 19.9 (13.7–26.0) 24.6 (23.4–25.9) 36.1 (34.5–37.6) 47.6 (44.9–50.3)
Smoking
Current regular (%) 28.6 31.7 (24.6–38.9) 32.3 (31.0–33.7) 26.6 (25.2–28.0) 21.2 (18.9–23.4)
Current occasional (%) 4.5 3.6 (0.7–6.4) 4.8 (4.2–5.4) 4.7 (4.0–5.4) 2.8 (1.9–3.7)
Non-smokers (former
and never, %)
66.9 64.7 (57.3–72.0) 62.9 (61.5–64.3) 68.7 (67.2–70.1) 76.0 (73.7–78.4)
Mean physical activity score 3.52 3.47 (3.17–3.77) 3.79 (3.74–3.84) 3.44 (3.39–3.49) 2.85 (2.76–2.94)
Mean diet score 3.51 3.51 (3.35–3.67) 3.54 (3.51–3.57) 3.51 (3.48–3.54) 3.39 (3.34–3.44)
Blood pressure (systolic/diastolic)
Mean systolic (mmHg) 129.3 117.4 (115.0–119.9) 124.5 (124.0–125.0) 132.2 (131.6–132.8) 138.9 (137.8–139.9)
Mean diastolic (mmHg) 78.9 71.1 (69.7–72.6) 76.1 (75.8–76.4) 80.8 (80.4–81.1) 84.2 (83.7–84.8)
C140 or C90 (%) 28.8 11.4 (6.5–16.2) 19.0 (17.9–20.2) 34.6 (33.1–36.1) 48.6 (45.9–51.4)
Cholesterol (C)
Total C: HDL C (ratio) 5.06 3.79 (3.62–3.97) 4.42 (4.38–4.47) 5.52 (5.46–5.58) 6.15 (6.03–6.27)
Ratio C 5 (%) 44.4 13.0 (7.8–18.3) 28.7 (27.4–30.0) 56.8 (55.2–58.4) 67.5 (64.9–70.1)
Deaths
All causes (n) 1,526 24 520 634 348
Cardiovascular disease (n) 448 8 126 187 127
Cancer (n) 636 2 232 268 134
* Based on height and weight measured at baseline
MONICA MONItoring of trends and determinants in CArdiovscular disease
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regression model including relevant independent variables
(age, sex, educational class, risk factors) and adjusting for
study wave. The association between BMI and death was
increasingly adjusted for additional variables using three
models: (1) age, sex and survey wave; (2) ? diet/physical
activity scores and smoking; (3) ? educational class. The
proportional hazards assumption was tested and checked by
visual inspection and seemed to be widely fulfilled. The
methods for the calculation of population attributable
fractions is described in the Web Annex. General
descriptive analyses and survival estimations were per-
formed with Stata 11 (Stata Corp, Texas, USA, 2009),
Kaplan–Meier curves and attributable deaths were obtained
with R 2.10.1 (The R Foundation for Statistical Computing,
2009).
Results
Descriptive crude analyses
Characteristics of participants are summarized in Table 1.
The number of underweight persons was small and mainly
consisted of women. In contrast, among obese, there were
about as many women as men. The prevalence of obesity
was higher than that based on a survey with self-reports but
in line with that based on a study with measurement of
height and weight in 2003 [21, 22]. Obese persons were
older, particularly when compared to normal weight par-
ticipants. Between BMI categories there were also differ-
ences regarding educational class and smoking status.
Variations in blood pressure and cholesterol were sub-
stantially larger than in physical activity and diet.
Kaplan–Meier curves decrease when a death occurs
(Fig. 1). The curves of overweight and obese persons
decrease more rapidly than the curve of normal weight
persons. However, one should consider that persons in the
different BMI categories also differed by sex and age:
normal weight persons were younger and more often
women. The curve of obese persons differs more strongly
from the curve of overweight persons in CVD than in
cancer deaths.
Adjusted analyses
Figure 2 shows HRs for all-cause mortality by BMI cate-
gory in smokers (regular and occasional) and non-smokers
(never and former). The curves have a J shape (non-
smokers) or a U shape (smokers), with increased HRs at
one or both extremes. Under- and normal- weight smokers
had in average a higher risk than obese non-smokers. In
both groups, overweight was not associated with higher
risk than normal weight. The increase in HRs at
BMI \ 20 kg/m2 was only due to an increase in men–in
women, HRs remained fairly unchanged. However, the
number of deaths was small and the confidence intervals
were overlapping between sexes. In contrast, increase in
HRs for BMI C 30 kg/m2 was almost identical in men and
women (sex differences not shown). The curve of the entire
population (smokers and non-smokers combined) is shown
in Web Annex Fig. 1.
Table 2 shows all-cause and cause-specific mortality
risk by BMI category. The results are adjusted with an
increasing number of variables leading to three different
models. For none of the cause of death groups and in none
of the models, overweight was associated with increased
mortality. Underweight tended to be associated with higher
CVD but with lower cancer mortality. The number of cases
was however, small in that group. After full adjustment,
mortality from all-causes among obese persons was 36%
higher than among normal weight persons. CVD mortality
was more strongly associated with obesity than cancer
mortality. Non-cancer-non-CVD deaths were comparably
more frequent among underweight than among normal
weight individuals. In underweight persons, HRs for CVD
and non-cancer-non-CVD deaths were higher in men than
in women but the differences did not reach statistical sig-
nificance (not shown). Generally, there were no funda-
mental differences between age groups (Web annex
Table 1). In separate analyses, adjustment for cholesterol
ratio and blood pressure substantially attenuated the asso-
ciation of obesity with CVD mortality by about 50%.
Nevertheless, this association remained statistically sig-
nificant. The relationship of CVD mortality with over-
weight was virtually not affected by the adjustment.
Figure 3 shows deaths attributable to obesity as
percentage of all deaths related to all death in the corre-
sponding group (all-cause, CVD, cancer, non-cancer-
non-CVD). Prevalence rates from studies with either
self-reported (empty diamonds) or measured height and
weight (filled circles) used for the calculation of attribut-
able deaths are given in the legend. Due to the higher
obesity prevalence, the proportion of attributable deaths
was higher when it was based on measured height and
weight: 4% (self-report) and 6.5% (measurement) of all
deaths were attributable to obesity. The proportions were
higher for CVD (8.8 and 13.7% of all CVD deaths) than for
cancer (2.4 and 3.9% of all cancer deaths).
Discussion
Main results
In this general Swiss population, obesity but not over-
weight was associated with increased risk of dying from
650 D. Faeh et al.
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CVD and, to a smaller extent, from cancer. The relation-
ship between BMI and all-cause mortality followed a
J shaped pattern in non-smokers and a U shape pattern in
smokers (Fig. 2). Among underweight persons, the ten-
dency to an increased risk was driven by CVD (men) and
non-cancer-non-CVD (men and women). However, this
relationship was confounded by smoking status. The rela-
tive risk of death associated with obesity remained
significantly increased after adjustment for lifestyle factors
and educational level (Table 2).
Overweight and obesity
A J- or U-shaped relationship between BMI and all-cause
mortality has been documented in most but not all cohort
studies [1, 3, 13, 15, 28–32]. A more pronounced U shape
A B
C D
Fig. 1 Kaplan–Meier curves of normal weight, overweight and obese
individuals for mortality from all causes (A), CVD (B), cancer
(C) and non-cancer-non-CVD (D), 9,853 participants of the Swiss
MONICA study, 1983–92, 25–74 years at baseline. MONICA
MONItoring of trends and determinants in CArdiovscular disease.
CVD Cardiovascular Disease. Body Mass index categories are based
on height and weight measured at baseline
Fig. 2 All-cause mortality
(hazard ratios with 95%
confidence interval) by smoking
status and BMI category,
adjusted for age, sex and study
wave, 9,853 participants of the
Swiss MONICA study,
1983–92, 25–74 years at
baseline. MONICA MONItoring
of trends and determinants in
CArdiovscular disease.
Reference category are non-
smokers with BMI
20.0–22.4 kg/m2. Asterisk
represents based on height and
weight measured at baseline
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comparable to ours was found in a MONICA-population
from Poland and in several other studies [1, 5, 12, 13, 29,
30]. The fact that we found no increased risk in overweight
persons was at variance with reports from Korea, Europe
and North America and China (in persons ages\65 years)
[1, 13, 29, 31], but in line with other European studies,
reports from India, the US and with results from older
populations [6, 12, 15, 29, 32–34]. In contrast to
overweight, obesity was associated with increased risk of
death in almost all available studies.
As shown by most others and by our study, the increased
mortality risk was mainly due to CVD [1, 3, 13, 15, 29, 31,
35]: the HRs of obese versus normal weight persons were
very similar to ours [1, 13, 15, 29, 31, 35]. In accordance
with our results, no or only a marginal increase in relative
CVD mortality risk in overweight persons was found in
Table 2 Adjusted hazard ratios for all-cause and cause specific mortality, by BMI category, 9,853 participants of the MONICA study, 1983–92,
25–74 years at baseline
Body mass index category (kg/m2)*
\18.5 18.5–24.9 25–29.9 C30
HR (95% CI) P HR HR (95% CI) P HR (95% CI) P
All cause
Model 1 1.32 (0.87–1.99) 0.187 1.00 0.96 (0.85–1.08) 0.455 1.41 (1.23–1.62) \0.001
Model 2 1.18 (0.78–1.80) 0.431 1.00 0.95 (0.85–1.07) 0.438 1.37 (1.19–1.58) \0.001
Model 3 1.21 (0.80–1.85) 0.367 1.00 0.94 (0.84–1.06) 0.329 1.36 (1.18–1.56) \0.001
Cardiovascular disease (CVD)
Model 1 1.62 (0.79–3.33) 0.189 1.00 1.10 (088–1.38) 0.407 2.05 (1.60–2.63 \0.001
Model 2 1.52 (0.74–3.13) 0.259 1.00 1.08 (0.86–1.35) 0.535 1.95 (1.52–2.51) \0.001
Model 3 1.60 (0.77–3.29) 0.206 1.00 1.07 (0.85–1.35) 0.551 1.92 (1.49–2.47) \0.001
Cancer
Model 1 0.26 (0.06–1.04) 0.056 1.00 0.96 (0.80–1.15) 0.647 1.29 (1.04–1.60) 0.021
Model 2 0.24 (0.06–0.98) 0.047 1.00 0.97 (0.81–1.16) 0.711 1.28 (1.03–1.60) 0.027
Model 3 0.25 (0.06–1.01) 0.051 1.00 0.94 (0.79–1.13) 0.519 1.25 (1.00–1.56) 0.050
Non-cancer-non-CVD
Model 1 2.54 (1.46–4.42) 0.001 1.00 0.86 (0.69–1.06) 0.158 1.10 (0.84–1.44) 0.488
Model 2 2.18 (1.23–3.88) 0.008 1.00 0.86 (0.69–1.07) 0.174 1.08 (0.82–1.42) 0.576
Model 3 2.22 (1.25–4.0) 0.006 1.00 0.86 (0.69–1.06) 0.162 1.08 (0.82–1.42) 0.585
* Based on height and weight measured at baseline
Model 1 (basic) adjusted for age, sex and survey wave
Model 2 (lifestyle) additionally adjusted for diet, physical activity and smoking
Model 3 (socio-economic status) additionally adjusted for education
MONICA MONItoring of trends and determinants in CArdiovscular disease
Fig. 3 Estimated excess deaths
in Switzerland attributable to
obesity, in percent of all causes
and cause-specific deaths, 9,853
participants of the Swiss
MONICA study, 1983–92,
25–74 years at baseline.
MONICA MONItoring of trends
and determinants in
CArdiovscular disease.
Analyses were adjusted for age
and sex
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Poland and the US [29, 35] while a small but significant
increase was reported in Europe and North America, China
and Korea [1, 13, 29, 31]. Our relative risks for cancer
mortality associated with obesity were somewhat higher
than those found in a large Asian-Pacific sample [36]. This
and two other samples showed a small but significant rel-
ative cancer risk in overweight persons, which was at odds
with our finding [3, 31, 36]. In a study including partici-
pants from Europe and North America, the increased risk
associated with higher BMI was substantially lower for
cancer than for CVD (HR per 5 kg/m2 of increase in BMI:
1.10 vs. 1.41) [1, 3]. In contrast, in a large Korean popu-
lation cancer and CVD mortality were similarly associated
with obesity [31].
In our study, lifestyle factors and educational level only
moderately attenuated excess risk of obese individuals.
Thus, there is little evidence for uncontrolled confounding.
However, in line with most literature a part of the CVD risk
associated with obesity was apparently mediated by high
blood pressure and cholesterol ratio [29, 31, 35]. In a meta-
analysis of 21 cohort studies, almost half of the increased
risk of fatal and nonfatal CHD events in overweight and
obese persons was explained by higher blood pressure and
cholesterol levels [37].
Others showed that fatal and non-fatal CVD events were
similarly associated with overweight and obesity [35].
Analogously, cancer incidence and morbidity were asso-
ciated with excess weight in a similar manner [4]. It is
therefore possible that, in Switzerland, corresponding to
mortality figures, there is also no increased relative risk for
CVD and cancer morbidity among overweight persons.
Underweight
Persons with underweight only contributed a small number
of deaths and results should therefore be interpreted cau-
tiously. In accordance with others, the relative risk of death
of underweight persons was higher in smokers than in non-
smokers (Fig. 2) [1, 3, 13, 31]. The tendency to higher
mortality risk of underweight persons was driven by death
from non-cancer to non-CVD. Our data did not offer suf-
ficient statistical power to assess which specific causes
were responsible for excess mortality in smokers and non-
smokers. Other studies showed that respiratory mortality
(e.g., COPD) substantially contributed [1, 13, 31, 38]. Most
but not all studies showed an increased CVD mortality at
BMI below 18.5 [1, 3, 13, 29–31].
The association between low BMI and death could
reflect insufficient consideration of early or chronic disease
leading to both thinness and death. Our data, however,
provide only little evidence for this: first, our population
was comparably young and age did not appear to funda-
mentally affect the relationship between BMI and mortality
risk; second, adjustment for smoking only marginally
attenuated estimates; third, the number of cancer deaths
was negligible among underweight persons and the pattern
(non-cancer-non-CVD [ CVD [ cancer) was the same as
in a large study considering only healthy subjects who
never smoked [3]. Furthermore, only 3.6 and 11.9% of all
non-injury deaths occurred during the first 2 and 5 years
after study entry. Others have shown that an increased risk
of death in underweight persons was still observed among
healthy participants and after exclusion of the initial
5 years of follow-up [3, 29, 39].
Excess deaths attributable to obesity
In Switzerland, nationally representative data on obesity
prevalence is only available from self-reports which sub-
stantially underestimate real obesity prevalence [40]. For
valid figures, excess deaths should be estimated with
obesity prevalence based on measured height and weight.
Since more recent data was not available, we used mea-
sured BMI data from 2003 for the calculation of excess
deaths. However, this should not substantially underesti-
mate current excess deaths because in Switzerland obesity
prevalence stagnated or increased only marginally since
2003 [41].
In the US, where obesity prevalence is about twice as
high as in Switzerland, approximately 29% of CVD deaths
and 8% of cancer deaths were attributable to
BMI C 25 kg/m2 [1, 11]. For the UK, the corresponding
proportions were 23 and 6%, respectively [1, 42]. In
accordance with our figures, a calculation based on Euro-
pean data estimated that in Switzerland around 700 cancer
cases/year could be attributed to overweight or obesity
[43]. Probably, our estimates would be higher, had we used
other markers than BMI for the definition of obesity (e.g.,
body fat percentage) [44]. However, a large European
study proved BMI to remain significantly associated with
the risk of death also in models that included waist cir-
cumference or waist-to-hip ratio [32].
Public health implications
Our findings do not support the concept that persons with
overweight should decrease their BMI in order to reduce
their risk of premature death. For this category (BMI
25–29.9) efforts aimed at avoiding weight gain and
improving health behaviour may be more appropriate. Our
study also implies that by controlling and treating risk
factors in obese persons, excess mortality risk can be
decreased but not eliminated. Because long term weight
loss is unrealistic in obese persons, the only way to
decrease excess deaths on a population level is to prevent
persons from becoming obese. Our results also show that
Obesity but not overweight 653
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the benefit of lower BMI does not counterweight the
increased risk associated with smoking. Thus, under- and
normal- weight smokers should be as consequently
screened and motivated for smoking cessation as obese
smokers.
Limitations
The MONICA participants included in our study had a
lower mortality and were thus, presumably more healthy
than the general Swiss population [20]. However, in a large
study conducted in an immediately neighbouring Austrian
region, the difference between expected and observed
mortality was even larger [13], but the observed patterns
were generally the same as in our study. Obese persons are
less likely to participate in health surveys than normal
weight persons and the ‘‘healthy participant effect’’ could
have distorted relative risks [45]. We also had only one
measurement of height and weight at study entry and could
not consider change in BMI during follow-up. Our obesity
marker was restricted to BMI and did not include waist
circumference, visceral fat or body fat percentage. To the
extent that BMI imperfectly reflects adiposity, our results
would tend to underestimate the deleterious effects of
obesity [44]. Our information on diet and physical activity
was based on a coarse assessment. However, the derived
scores were significantly associated with mortality (not
shown). Our information on pre-existing disease was
restricted to known hypertension. Inclusion of this variable
in the model only minimally affected estimates. Also for
other reasons discussed above, we have little evidence that
severe disease existing before study entry played a major
role in our population. We also found no evidence that age
affected the obesity-mortality relationship.
Conclusion
In this study from Switzerland, obesity but not overweight
was associated with an increased risk of death. Excess
mortality was driven by CVD and, to a smaller extent, by
cancer. After adjustment for lifestyle risk factors and for
educational class, the independent effect of obesity
decreased but remained significant. Our results question the
targeting of overweight individuals for weight loss pro-
grams in order to decrease burden of disease. In contrast,
people should be prevented from becoming obese—irre-
spective of their body weight. In smokers, underweight was
significantly associated with premature death, mainly due
to non-cancer-non-CVD causes.
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